Viewing Study NCT02149706


Ignite Creation Date: 2025-12-26 @ 5:18 PM
Ignite Modification Date: 2026-04-20 @ 2:33 AM
Study NCT ID: NCT02149706
Status: UNKNOWN
Last Update Posted: 2020-03-11
First Post: 2014-05-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis
Sponsor: Immune Response BioPharma, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Sclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Secondary Progress Multiple Sclerosis View
None SPMS View
None Multiple Sclerosis View
None NeuroVax View